Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.470
-0.050 (-1.98%)
Feb 27, 2026, 4:00 PM EST - Market closed
CNTB Employees
Connect Biopharma Holdings had 62 employees as of December 31, 2024. The number of employees decreased by 19 or -23.46% compared to the previous year.
Employees
62
Change (1Y)
-19
Growth (1Y)
-23.46%
Revenue / Employee
$12,290
Profits / Employee
-$794,790
Market Cap
138.08M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 62 | -19 | -23.46% |
| Dec 31, 2023 | 81 | -19 | -19.00% |
| Dec 31, 2022 | 100 | -8 | -7.41% |
| Jan 1, 2022 | 108 | 46 | 74.19% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Adagene | 138 |
| Artiva Biotherapeutics | 106 |
| Immunic | 90 |
| Cardiff Oncology | 31 |
| Black Diamond Therapeutics | 24 |
| Genelux | 24 |
| Unicycive Therapeutics | 23 |
CNTB News
- 9 days ago - Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 6 weeks ago - Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - GlobeNewsWire
- 3 months ago - Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript - Seeking Alpha
- 5 months ago - Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025 - GlobeNewsWire
- 6 months ago - Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025 - GlobeNewsWire
- 6 months ago - Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq - GlobeNewsWire